Tedizolid, Faropenem, and Moxifloxacin Combination With Potential Activity Against Nonreplicating Mycobacterium tuberculosis
Background:Mycobacteriumtuberculosis [Mtb] could be present in different metabolic population in the lung lesions, and nonreplicating persisters [NRP], associated with latent tuberculosis [TB], are the most difficult to kill.Objective: Test the combination of tedizolid, moxifloxacin, and faropenem f...
Saved in:
Main Authors: | Shashikant Srivastava (Author), Kayle N. Cirrincione (Author), Devyani Deshpande (Author), Tawanda Gumbo (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Repurposing Cefazolin-Avibactam for the Treatment of Drug Resistant Mycobacterium tuberculosis
by: Shashikant Srivastava, et al.
Published: (2021) -
Minocycline intra-bacterial pharmacokinetic hysteresis as a basis for pharmacologic memory and a backbone for once-a-week pan-tuberculosis therapy
by: Devyani Deshpande, et al.
Published: (2022) -
Cefdinir and β-Lactamase Inhibitor Independent Efficacy Against Mycobacterium tuberculosis
by: Shashikant Srivastava, et al.
Published: (2021) -
Comparison of Rifamycins for Efficacy Against Mycobacterium avium Complex and Resistance Emergence in the Hollow Fiber Model System
by: Gunavanthi D. Boorgula, et al.
Published: (2021) -
Anidulafungin in the treatment of invasive fungal infections
by: Kathryn Sabol, et al.
Published: (2008)